ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
The CIA has long been concerned biological threats, including the use of anthrax bacteria, seen above.   © Reuters
The Big Story

China and the new frontier of biosecurity threats

Security experts warn of 'biological extortion' and other emerging risks

HENNY SENDER, Nikkei Asian Review columnist | China

HONG KONG -- When it comes to China and biotechnology, U.S. policy is influenced by a mix of economic considerations, geopolitical issues, reasonable fears and excessive paranoia. All were on display at a congressional committee hearing on the subject in Washington last year.

The hearing -- "China's Pursuit of Next Frontier Tech: Computing, Robotics and Biotechnology" -- was held to examine the national security implications of China's growth as a tech powerhouse. The committee noted that China's five-year industrial plan, outlined in 2016, sought to push further into "dual-use" technologies that have civilian and military applications.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more